CAMBRIDGE, Mass., Nov. 1 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the upcoming Cowen and Company 7th Annual Global Healthcare Conference on Tuesday, November 7, 2006 at 9:20 a.m. (GMT) at the Landmark Hotel, London; ThinkEquity’s ThinkTank Summit on Friday, November 10, 2006 at 8:40 a.m. (EST) at the Ritz Carlton, New York City Midtown; and at Bear Stearns’ SMid-Cap Investor Conference on Tuesday, November 14, 2006 at 4:20 p.m. (EST) at Bear Stearns Headquarters, New York.
The live and archived webcasts of the presentations can be accessed under “Calendar of Events” in the Idenix Investor Center at http://ir.idenix.com/phoenix.zhtml?c=131556&p=irol-calendar. The archived replays will be available on the Idenix website for two weeks following the presentations.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals’ Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
Idenix Pharmaceuticals, Inc.
CONTACT: Media: Teri Dahlman, +1-617-995-9905, or Investors: Amy Sullivan,+1-617-995-9838, both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
